Patients seeking stem cell therapy for MSA (multiple system atrophy) can save 50-70% on treatment costs by choosing Colombia over the United States or Germany. Colombian facilities provide complete treatment packages between $5,000 and $15,000, while Western countries maintain premium rates.
Regencord leads the stem cell therapy field from its center in Pereira, Colombia. The facility treats neurological conditions of all types, including Multiple System Atrophy (MSA). Their advanced treatment protocols and exceptional patient care have established them as a premier destination. Neurodegenerative disease treatments at Regencord typically cost between $7,000 and $15,000.
This piece covers everything patients should know about an MSA treatment stem cell at Regencord. Readers will discover the science behind stem cell therapy, detailed 2025 cost breakdowns, and clinical outcomes.
“Stem cell research can revolutionize medicine, more than anything since antibiotics.” — Ronald Reagan, 40th President of the United States
Multiple System Atrophy (MSA) is a rare neurodegenerative disorder that affects about 3.4 to 4.9 people per 100,000. People first show symptoms after age 30. Most cases begin between ages 50 and 59, and the disease progresses faster. This progression has a dramatic effect on the patient’s quality of life.
MSA damages specific areas of the brain – mainly the cerebellum, basal ganglia, and brainstem. This damage leads to widespread problems with neurological function. The multiple system atrophy diagnosis is based on a combination of clinical symptoms and neuroimaging findings. The condition shows up in two main types:
Regencord leads advanced protocols in MSA treatment stem cell therapy that focuses on both effectiveness and patient safety. Their approach combines innovative technology with customized care to help patients with this challenging neurological condition.
Regencord Laboratories follows strict ISO standards, including ISO 9001 for management systems and ISO 22859 for human mesenchymal stromal cell banking. The facility’s protocols maximize therapeutic benefits while reducing risks. Their methods focus on changing the disease course rather than just managing symptoms, unlike traditional MSA treatments. Their approach recognizes that MSA needs a multi-disciplinary treatment strategy that combines stem cell therapy with supportive care.
The financial side of MSA treatment stem cell therapy is vital for patients thinking about this treatment. Regencord’s cost structure shows both the advanced nature of the treatment and the economic benefits of getting care in Colombia.
The standard MSA treatment stem cell therapy package at Regencord will cost between $7,000 and $15,000 in 2025. The price changes based on how severe the condition is and how complex the protocol needs to be. This base package has stem cell administration, main medical evaluations, and needed follow-up care. Several factors affect the pricing:
Simple stem cell therapies start under $5,000, but complex neurological treatments can cost more than $25,000.
“The next age of medicine will revolve around stem cells.” — Peter Diamandis, Founder and Executive Chairman of the XPRIZE Foundation
Research on stem cell therapy for MSA treatment has shown promising results. This brings new hope to patients who face this challenging neurological disorder.
Clinical trials have shown measurable benefits for MSA patients who receive stem cell therapy. A random study of MSA-C patients revealed that people who received autologous mesenchymal stem cells had much smaller increases in UMSARS scores compared to those who got placebos. This shows slower disease progression. The treated group managed to keep better cerebral glucose metabolism and gray matter density even after 360 days.
Seven MSA patients who received human umbilical cord blood mononuclear cells showed their best results 3-6 months after treatment. Their UMSARS scores were substantially lower compared to baseline (25.71 ± 11.87 vs. 42.57 ± 7.96).
Stem cell therapy brings new hope to MSA patients looking for a treatment that works. Studies show it can slow down the disease in several ways. Regencord’s advanced methods help patients get these benefits at much lower costs than Western treatments.
Research backs up stem cell therapy’s effectiveness in treating MSA. Patients see their symptoms progress more slowly and live better lives. The therapy isn’t a cure but helps protect nerves, regulates the immune system, and repairs cells more effectively. It addresses both motor symptoms and autonomic dysfunction associated with MSA.
Regencord combines expert knowledge, detailed care plans, and budget-friendly treatment packages. Their services are now available to more patients around the world. High success rates and complete follow-up care give MSA patients a clear path to handle this tough condition.
MSA patients should take the time to review their treatment choices. Starting treatment early often brings better results. Science and Regencord’s proven results show that stem cell therapy helps fight MSA effectively. It offers real solutions when regular symptomatic treatment doesn’t deliver enough relief. As research continues, stem cell therapy may become a key component of multiple system atrophy alternative treatments, offering hope for improved quality of life for MSA patients. Schedule a consultation with Regencord and experience the difference!
3-Step Process for Stem Cell Treatment for Arthritis in Hands
Stem cells are unique cells with the ability to develop into various cell types and repair damaged tissues. They are used in regenerative medicine, including treatments for cancer, neurodegenerative diseases, and injuries. Sources include bone marrow, cord blood, and embryos.
(888) 540-4101
Begin your journey with us today! Call us at (888) 540-4101 or complete the form to learn more.
